Glenn S.  Boehnlein net worth and biography

Glenn Boehnlein Biography and Net Worth

CFO of Stryker

Glenn is responsible for our global finance activities which include corporate accounting, reporting, tax, treasury and internal audit. His role expanded in January 2020 and he now also oversees our global information services function.

In 2003, Glenn began his career with us as vice president of finance and information technology for our Endoscopy division. Since then, he has taken on roles of increasing responsibility including group CFO of MedSurg and Neurotechnology.

Prior to joining us, Glenn spent three years with Success TV as CFO. Prior to that, he was a partner and certified public accountant at Arthur Andersen. He received his bachelor’s and master’s degrees in accounting from Mississippi State University.

What is Glenn S. Boehnlein's net worth?

The estimated net worth of Glenn S. Boehnlein is at least $1.10 million as of August 2nd, 2024. Mr. Boehnlein owns 2,852 shares of Stryker stock worth more than $1,099,959 as of November 21st. This net worth approximation does not reflect any other investments that Mr. Boehnlein may own. Additionally, Mr. Boehnlein receives an annual salary of $2,270,000.00 as CFO at Stryker. Learn More about Glenn S. Boehnlein's net worth.

How old is Glenn S. Boehnlein?

Mr. Boehnlein is currently 62 years old. There are 6 older executives and no younger executives at Stryker. Learn More on Glenn S. Boehnlein's age.

What is Glenn S. Boehnlein's salary?

As the CFO of Stryker Co., Mr. Boehnlein earns $2,270,000.00 per year. The highest earning executive at Stryker is Mr. Kevin A. Lobo, Chairman, CEO & President, who commands a salary of $5,700,000.00 per year. Learn More on Glenn S. Boehnlein's salary.

How do I contact Glenn S. Boehnlein?

The corporate mailing address for Mr. Boehnlein and other Stryker executives is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. Stryker can also be reached via phone at (269) 385-2600 and via email at [email protected]. Learn More on Glenn S. Boehnlein's contact information.

Has Glenn S. Boehnlein been buying or selling shares of Stryker?

Glenn S. Boehnlein has not been actively trading shares of Stryker during the last quarter. Most recently, Glenn S. Boehnlein sold 20,000 shares of the business's stock in a transaction on Friday, August 2nd. The shares were sold at an average price of $333.00, for a transaction totalling $6,660,000.00. Following the completion of the sale, the chief financial officer now directly owns 2,852 shares of the company's stock, valued at $949,716. Learn More on Glenn S. Boehnlein's trading history.

Who are Stryker's active insiders?

Stryker's insider roster includes Yin Becker (VP), William Berry, Jr. (VP), Glenn Boehnlein (CFO), Srikant Datar (Director), Roch Doliveux (Director), M. Fink (VP), Robert Fletcher (VP), Allan Golston (Director), Kevin Lobo (CEO), Katherine Owen (VP), James Pierce (Insider), Bijoy Sagar (VP), Timothy Scannell (COO), and Ronda Stryker (Director). Learn More on Stryker's active insiders.

Are insiders buying or selling shares of Stryker?

In the last year, insiders at the medical technology company sold shares 10 times. They sold a total of 490,063 shares worth more than $165,955,919.20. The most recent insider tranaction occured on November, 7th when CEO Kevin Lobo sold 57,313 shares worth more than $21,131,303.10. Insiders at Stryker own 5.5% of the company. Learn More about insider trades at Stryker.

Information on this page was last updated on 11/7/2024.

Glenn S. Boehnlein Insider Trading History at Stryker

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/2/2024Sell20,000$333.00$6,660,000.002,852View SEC Filing Icon  
2/2/2023Sell24,425$278.54$6,803,339.502,428View SEC Filing Icon  
12/10/2021Sell2,778$259.79$721,696.62View SEC Filing Icon  
3/1/2021Sell2,000$246.01$492,020.0012,321View SEC Filing Icon  
12/28/2020Sell2,000$239.10$478,200.0014,321View SEC Filing Icon  
6/15/2020Sell10,351$185.24$1,917,419.2416,321View SEC Filing Icon  
10/30/2019Sell2,700$215.85$582,795.0017,933View SEC Filing Icon  
7/30/2019Sell2,700$214.16$578,232.0020,633View SEC Filing Icon  
5/8/2019Sell2,700$188.21$508,167.0023,333View SEC Filing Icon  
10/1/2018Sell750$178.17$133,627.502,785View SEC Filing Icon  
4/16/2018Sell750$160.00$120,000.003,535View SEC Filing Icon  
4/27/2016Sell2,000$109.61$219,220.002,509View SEC Filing Icon  
See Full Table

Glenn S. Boehnlein Buying and Selling Activity at Stryker

This chart shows Glenn S Boehnlein's buying and selling at Stryker by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Stryker Company Overview

Stryker logo
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical and thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, clinical communication and workflow solutions, and other medical device products that are used in various medical specialties, as well as patient and caregiver safety technologies. This segment also provides neurosurgical, neurovascular and craniomaxillofacial implant products, which include products used for minimally invasive endovascular procedures; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Read More

Today's Range

Now: $385.68
Low: $382.25
High: $390.00

50 Day Range

MA: $365.46
Low: $345.14
High: $390.08

2 Week Range

Now: $385.68
Low: $285.79
High: $398.20

Volume

1,063,118 shs

Average Volume

1,488,249 shs

Market Capitalization

$147.03 billion

P/E Ratio

41.34

Dividend Yield

0.82%

Beta

0.91